retatrutide study triple agonist weight loss trial Today we shared new results on retatrutide, an investigational, first Retatrutide vs Tirzepatide: Which Peptide

Why employers are facing a tough decision Why covering GLP-1s is a costly challenge for employers GLP-1 medications like Wegovy and Ozempic are among the most expensive prescription drugs available today

While there is no official clinical guidance supporting this practice, individual tolerance patterns vary, and patients should discuss timing strategies with their healthcare provider if side effects are problematic

Microdosing lets you use each injection pen for longer, lowering your total cost

Many of the same drugs can interact with Vyvanse

After 56 weeks, the study participants in the liraglutide group achieved an 8.4% weight loss compared to 2.8% in the placebo group (95% CI: 6.0 to 5.1

They specialize in GLP-1s for women in perimenopause and menopause, and their platform tailors everything to your symptoms